Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | CASP7 | P55210 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8293341 | 1.00 | L3MBTL1 (0.60) | L3MBTL1POLBSMN1; SMN2MEN1CYP2C19 | |
| SCHEMBL8292876 | 0.95 | POLB (0.58) | L3MBTL1POLBSMN1; SMN2MEN1CYP2C19 | |
| SCHEMBL14477978 | 0.94 | POLB (0.56) | L3MBTL1POLBSMN1; SMN2MEN1CYP2C19 | |
| SCHEMBL15082405 | 0.94 | POLB (0.56) | L3MBTL1POLBSMN1; SMN2MEN1CYP2C19 | |
| SCHEMBL8084202 | 0.94 | POLB (0.56) | L3MBTL1POLBSMN1; SMN2MEN1CYP2C19 | |
| SCHEMBL119623 | 0.94 | POLB (0.56) | L3MBTL1POLBSMN1; SMN2MEN1CYP2C19 | |
| SCHEMBL8084223 | 0.94 | POLB (0.56) | L3MBTL1POLBSMN1; SMN2MEN1CYP2C19 | |
| SCHEMBL8076306 | 0.94 | POLB (0.56) | L3MBTL1POLBSMN1; SMN2MEN1CYP2C19 | |
| SCHEMBL14477954 | 0.94 | POLB (0.56) | L3MBTL1POLBSMN1; SMN2MEN1CYP2C19 | |
| SCHEMBL2890516 | 0.94 | POLB (0.56) | L3MBTL1POLBSMN1; SMN2MEN1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118742283-A | Cosmetic or dermatological composition comprising a merocyanine and gamma-butyrolactone and/or gamma-butyrolactam | 莱雅公司 | 2024-10-01 | — | — | CN | disclosed |
| US-20240238188-A1 | OILY COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240238188-A1 | OILY COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| WO-2023110767-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND A GAMMA-BUTYROLACTONE AND/OR A GAMMA-BUTYROLACTAM | L'OREAL (FR) | 2023-06-22 | — | — | WO | disclosed |
| EP-2734180-B1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES | OREAL (FR) | 2021-03-31 | — | — | EP | disclosed |
| EP-2579842-B1 | COMPOSITION COMPRISING AT LEAST ONE 2-PYRROLIDONE FUNCTIONALIZED IN THE 4 POSITION WITH A CARBOXYLIC ACID OR AMIDE, AND AT LEAST ONE DIRECT DYE OR A PIGMENT FOR DYEING KERATIN FIBRES | ORÉAL L (FR) | 2016-03-30 | — | — | EP | disclosed |
| US-20140294743-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES | L'OREAL (FR) | 2014-10-02 | — | — | US | disclosed |
| US-20140294743-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES | L'OREAL (FR) | 2014-10-02 | — | — | US | disclosed |
| US-8585779-B2 | Composition comprising at least one 2-pyrrolidone functionalized in the 4 position with a carboxylic acid or amide, and at least one direct dye or a pigment for dyeing keratin fibres | L'OREAL (FR) | 2013-11-19 | — | — | US | disclosed |
| US-8585779-B2 | Composition comprising at least one 2-pyrrolidone functionalized in the 4 position with a carboxylic acid or amide, and at least one direct dye or a pigment for dyeing keratin fibres | L'OREAL (FR) | 2013-11-19 | — | — | US | disclosed |
| WO-2008132195-A1 | ANTI-FOULING COATING COMPOSITIONS CONTAINING A CARBOXYL-FUNCTIONAL ORGANOSILICONE | AKZO NOBEL COATINGS INTERNATIONAL B.V. (NL) | 2008-11-06 | — | — | WO | disclosed |
| EP-1660447-B1 | CYCLIC AMINE BACE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT | SCHERING CORP (US) | 2008-07-30 | — | — | EP | disclosed |
| WO-2005014540-A1 | CYCLIC AMINE BASE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT | SCHERING CORPORATION (US) | 2005-02-17 | — | — | WO | disclosed |
| EP-1180513-A1 | CYCLIC AMIDE COMPOUNDS, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2002-02-20 | — | — | EP | disclosed |
| US-4987210-A | COMPLEXING IODINE AND WATER-INSOLUBLE DRUGS TO MAKE THEM MORE SOLUBLE | GAF CHEMICALS CORPORATION (US) | 1991-01-22 | — | — | US | disclosed |
| US-4985521-A | COPOLYMERS, COMPLEXES WITH WATER INSOLUBLE MOLECULES | GAF CHEMICALS CORPORATION (US) | 1991-01-15 | — | — | US | disclosed |
| US-4946967-A | CHEMICAL INTERMEDIATES FOR HIGH MOLECULAR WEIGHT ACYCLIC ESTER OR AMIDE | GAF CHEMICALS CORPORATION (US) | 1990-08-07 | — | — | US | disclosed |
| WO-1990005131-A1 | POLYMERIZABLE DERIVATIVES OF 5-OXO-PYRROLINE CARBOXYLIC ACID, POLYMERS THEREOF AND METHODS OF PREPARATION | GAF CHEMICALS CORPORATION (US) | 1990-05-17 | — | — | WO | disclosed |
| EP-0069512-B1 | SALTS OF N-SUBSTITUTED-2-PYRROLIDONE-4-CARBOXYLIC ACIDS AS HUMECTANTS | PFIZER INC. (US) | 1986-06-04 | — | — | EP | disclosed |
| EP-0069512-A2 | Salts of N-substituted-2-pyrrolidone-4-carboxylic acids as humectants | PFIZER INC. (US) | 1983-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238188-A1 | OILY COSMETIC | CUTA, HES1, SMO | L3MBTL1 806/4885POLB 1580/4885SMN1; SMN2 1566/4885 |
| US-20140294743-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES | KRT18, LAGE3, TYR | L3MBTL1 4454/4885POLB 2028/4885SMN1; SMN2 4825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.